Syndax Pharmaceuticals SNDX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 12.29 | 109.07 | -0.98 | -83,757 | -85 | |
| 2024Q4 | 13.22 | 107.84 | -1.09 | -96,365 | -94 | |
| 2024Q3 | 19.25 | 106.51 | -0.98 | -89,577 | -84 | |
| 2024Q2 | 20.53 | 109.11 | -0.80 | -74,216 | -68 | |
| 2024Q1 | 23.80 | 109.91 | -0.85 | -79,514 | -72 | |
| 2023Q4 | 21.61 | 107.59 | -1.01 | -77,905 | -72 | |
| 2023Q3 | 14.52 | 110.34 | -0.74 | -56,355 | -51 | |
| 2023Q2 | 20.93 | 111.44 | -0.64 | -49,679 | -45 | |
| 2023Q1 | 21.12 | 112.00 | -0.59 | -46,015 | -41 | |
| 2022Q4 | 25.45 | 107.36 | -0.62 | -42,033 | -39 | |
| 2022Q3 | 24.03 | 104.42 | 1661.69 | -0.59 | -35,141 | -35 |
| 2022Q2 | 19.24 | 102.30 | 69.89 | -0.62 | -37,725 | -38 |
| 2022Q1 | 17.38 | 100.93 | 38.36 | -0.63 | -36,858 | -37 |
| 2021Q4 | 21.89 | 99.54 | 1.84 | 95,749 | 96 | |
| 2021Q3 | 19.11 | 100.21 | -0.40 | -20,032 | -21 | |
| 2021Q2 | 17.17 | 100.26 | -0.44 | -22,334 | -23 | |
| 2021Q1 | 22.36 | 100.23 | -0.54 | -27,163 | -28 | |
| 2020Q4 | 22.24 | 100.37 | -0.44 | -19,861 | -20 | |
| 2020Q3 | 14.76 | 100.25 | -0.46 | -19,852 | -20 | |
| 2020Q2 | 14.82 | 101.13 | -0.41 | -16,610 | -17 |